Jie D’Elia is the Executive Director, Business Development Transactions at Bristol-Myers Squibb. In this role, Jie serves as the global lead in negotiating business development and licensing transactions.
Prior to joining Bristol-Myers Squibb in 2013, Jie served as the Corporate Vice President and Global Head of Business Development at Simcere Pharmaceutical, a fast growing leading Chinese pharmaceutical company with presence in North America and Europe. While at Simcere, she led the conceptualization and negotiation of a series of first-in-kind, high impact strategic partnerships, including a joint venture between Simcere and Merck Sharp & Dohme. Prior to joining Simcere, Jie worked at AstraZeneca and the Boston Consulting Group.
Jie holds a Ph.D. in Pharmacy from the University of Texas at Austin and an M.B.A from Columbia Business School.